Andres Maldonado HC Wainwright & Co Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
50
Avg Return
Past Year
Past Year
16%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
94.7%
Neutral
5.3%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Reiterated
| $23 |
317%
upside
| 2 | +12% |
0
%
| 3 Dec ‘25 2 days ago |
|
|
|
Buy
Reiterated
| $25 |
215%
upside
| 1 | -10% |
0
%
| 24 Nov ‘25 11 days ago |
|
|
|
Buy
Maintained
| $7 |
542%
upside
| 1 | -10% |
0
%
| 13 Nov ‘25 22 days ago |
|
|
|
Buy
Upgraded
| $20 |
31%
downside
| 1 | +110% |
0
%
| 4 Nov ‘25 1 month ago |
|
|
|
Buy
Reiterated
| $40 |
97%
upside
| 2 | +20% |
0
%
| 27 Oct ‘25 1 month ago |
|
|
|
Buy
Reiterated
| $40 |
289%
upside
| 2 | +24% |
0
%
| 20 Oct ‘25 1 month ago |
|
|
|
Neutral
Downgraded
| $97 |
1%
upside
| 1 | – |
–
| 30 Sep ‘25 2 months ago |
|
|
|
Buy
Reiterated
| $23 |
332%
upside
| 1 | -4.7% |
0
%
| 29 Sep ‘25 2 months ago |
|
|
|
Buy
Maintained
| $105 |
29%
upside
| 1 | +79% |
0
%
| 29 Sep ‘25 2 months ago |
|
|
|
Buy
Maintained
| $44 |
2%
downside
| 1 | +38% |
0
%
| 23 Sep ‘25 2 months ago |
|
|
|
Buy
Reiterated
| $75 |
73%
upside
| 3 | +4.8% |
0
%
| 15 Sep ‘25 2 months ago |
|
|
|
Buy
Reiterated
| $25 |
211%
upside
| 2 | +9.4% |
0
%
| 12 Sep ‘25 2 months ago |
|
|
|
Buy
Reiterated
| $8 |
249%
upside
| 1 | -2.7% |
0
%
| 10 Sep ‘25 2 months ago |
|